期刊文献+
共找到593篇文章
< 1 2 30 >
每页显示 20 50 100
Propylamine hydrobromide passivated tin-based perovskites to efficient solar cells
1
作者 Xiaomeng Li Pengcheng Jia +7 位作者 Fanwen Meng Xingyu Zhang Yang Tang Bo Song Chang Gao Liang Qin Feng Teng Yanbing Hou 《International Journal of Minerals,Metallurgy and Materials》 SCIE EI CAS CSCD 2023年第10期1965-1972,共8页
The development of tin-based devices with low toxicity is critical for the commercial viability of perovskite solar cells.However because tin halide is a stronger Lewis acid,its crystallization rate is extremely fast,... The development of tin-based devices with low toxicity is critical for the commercial viability of perovskite solar cells.However because tin halide is a stronger Lewis acid,its crystallization rate is extremely fast,resulting in the formation of numerous defects that affect the device performance of tin-based perovskite solar cells.Herein,propylamine hydrobromide(PABr)was added to the perovskite precursor solution as an additive to passivate defects and fabricate more uniform and dense perovskite films.Because propylamine cations are too large to enter the perovskite lattices,they only exist at the grain boundary to passivate surface defects and promote crystal growth in a preferred orientation.The PABr additive raises the average short-circuit current density from 19.45 to 25.47 mA·cm^(-2)by reducing carrier recombination induced by defects.Furthermore,the device’s long-term illumination stability is improved after optimization,and the hysteresis effect is negligible.The addition of PABr results in a power conversion efficiency of 9.35%. 展开更多
关键词 tin-based perovskite solar cells propylamine hydrobromide PASSIVATION crystallization
下载PDF
Anisodine hydrobromide alleviates oxidative stress caused by hypoxia/reoxygenation in human cerebral microvascular endothelial cells predominantly via inhibition of muscarinic acetylcholine receptor 4
2
作者 WENLI JIANG JUNYI SHEN +5 位作者 XIAOQIANG DU YAN QIU JIAN ZHONG ZHI OUYANG BINGMEI M.FU YE ZENG 《BIOCELL》 SCIE 2023年第10期2255-2263,共9页
Background:Anisodine hydrobromide(AT3),an anti-cholinergic agent,could be delivered to the brain across the blood-brain barrier and has been used clinically for the treatment of cerebral ischemia/reperfusion injury.En... Background:Anisodine hydrobromide(AT3),an anti-cholinergic agent,could be delivered to the brain across the blood-brain barrier and has been used clinically for the treatment of cerebral ischemia/reperfusion injury.Endothelial dysfunction can be caused by hypoxia/reoxygenation(H/R)via oxidative stress and metabolic alterations.The present study investigated whether AT3 regulates the production of nitric oxide(NO)and reactive oxygen species(ROS),and the HIF-1αpathway via regulation of muscarinic acetylcholine receptors(mAChRs)in brain microvascular endothelial cells after H/R exposure.Methods:Under H/R conditions,hCMEC/D3 cerebral microvascular endothelial cells were treated with AT3.Specific inhibitors of M2-and M4-mAChRs were used to explore the mechanism by which AT3 influences oxidative stress in endothelial cells.Then,mAChRs expression was detected by western blotting and NO production was detected by Greiss reaction.The intracellular ROS level was measured using DCFH-DA probes.The expression of hypoxia-inducible transcription factor 1α(HIF-1α)was also detected.Results:While H/R induced the expression of M2-and M4-mAChRs,AT3 suppressed the H/R-upregulated M2-and M4-mAChRs.H/R also induced the production of NO,ROS,and apoptosis.AT3 and M4-mAChR inhibitors inhibited the H/R-induced production of NO and ROS and apoptosis.HIF-1αwas induced by H/R,but was suppressed by AT3.Conclusion:Thus,the in vitro evidence shows that AT3 protects against H/R injury in cerebral microvascular endothelial cells via inhibition of HIF-1α,NO and ROS,predominantly through the downregulation of M4-mAChR.The findings offer novel understandings regarding AT3-mediated attenuation of endothelial cell apoptosis and cerebral ischemia/reperfusion injury. 展开更多
关键词 HYPOXIA/REOXYGENATION Endothelial cell Anisodine hydrobromide Muscarinic acetylcholine receptors Hypoxia-inducible factor-1α
下载PDF
疏肝理气养血方联合氢溴酸西酞普兰治疗卒中后失眠伴抑郁老年患者的疗效观察及对睡眠质量和神经递质的影响
3
作者 徐明超 樊书领 +1 位作者 李尽义 任应国 《中国合理用药探索》 CAS 2024年第1期98-103,共6页
目的:观察疏肝理气养血方联合氢溴酸西酞普兰治疗卒中后失眠伴抑郁老年患者的疗效及对睡眠质量和神经递质的影响。方法:选取2021年5月~2023年2月某院收治的114例卒中后失眠伴抑郁的老年患者为研究对象,采用随机数字表法分为对照组与观察... 目的:观察疏肝理气养血方联合氢溴酸西酞普兰治疗卒中后失眠伴抑郁老年患者的疗效及对睡眠质量和神经递质的影响。方法:选取2021年5月~2023年2月某院收治的114例卒中后失眠伴抑郁的老年患者为研究对象,采用随机数字表法分为对照组与观察组,每组57例。对照组给予氢溴酸西酞普兰片,观察组在对照组治疗基础上加用疏肝理气养血方。比较两组神经递质的水平[5-羟色胺(5-HT)、P物质(SP)、甘氨酸、γ-氨基丁酸],评估两组美国国立卫生院卒中量表(NIHSS)评分、匹兹堡睡眠质量指数(PSQI)评分、中医症状评分、汉密尔顿抑郁量表(HAMD)评分、日常生活能力(ADL)评分的差异。比较两组临床治疗总有效率并记录治疗期间两组不良反应的发生情况。结果:治疗后,两组患者5-HT、甘氨酸、γ-氨基丁酸均较治疗前升高,且观察组高于对照组(P<0.05);SP较治疗前降低,且观察组低于对照组(P<0.05);NIHSS评分、PSQI评分、HAMD评分、中医症状评分均较治疗前降低,且观察组PSQI评分、HAMD评分、中医症状评分低于对照组(P<0.05);ADL评分较治疗前升高,且观察组高于对照组(P<0.05)。治疗后,观察组临床治疗总有效率(91.23%)高于对照组(77.19%,P<0.05)。治疗期间两组患者不良反应总发生率比较无统计学差异。结论:疏肝理气养血方联合氢溴酸西酞普兰可有效改善卒中后失眠伴抑郁老年患者的抑郁和失眠症状,提高睡眠质量,调节神经递质的表达,提高临床疗效,且不增加不良反应的发生风险。 展开更多
关键词 疏肝理气养血方 氢溴酸西酞普兰 抑郁 卒中 失眠 神经递质
下载PDF
酮咯酸氨丁三醇与氢溴酸山莨菪碱在输尿管结石导致的急性肾绞痛患者中的应用效果比较
4
作者 杜剑 孔蕊红 +1 位作者 左永波 陈庆军 《中国医刊》 CAS 2024年第1期83-85,共3页
目的 比较酮咯酸氨丁三醇与氢溴酸山莨菪碱在输尿管结石导致的急性肾绞痛患者中的应用效果。方法 回顾性分析2020年1月至2022年1月于北京市海淀医院急诊外科就诊的166例输尿管结石导致的急性肾绞痛患者的临床资料,采用随机数字法将研究... 目的 比较酮咯酸氨丁三醇与氢溴酸山莨菪碱在输尿管结石导致的急性肾绞痛患者中的应用效果。方法 回顾性分析2020年1月至2022年1月于北京市海淀医院急诊外科就诊的166例输尿管结石导致的急性肾绞痛患者的临床资料,采用随机数字法将研究对象分为对照组(肌内注射氢溴酸山莨菪碱,81例)和观察组(肌内注射酮咯酸氨丁三醇,85例)。比较分析两组患者用药前以及用药后30 min、1 h、4 h的疼痛程度,用药后30 min的临床疗效,用药期间的不良反应发生情况。结果 与用药前比较,两组患者用药后30 min、1 h、4 h的视觉模拟评分法(VAS)评分均降低,差异均有统计学意义(P<0.05)。用药前,两组患者的VAS评分比较差异无统计学意义(P>0.05);用药后30 min、1 h、4 h,观察组患者的VAS评分均低于对照组,差异均有统计学意义(P<0.05)。用药后30 min,观察组患者的总有效率高于对照组,差异有统计学意义(P<0.05)。观察组患者用药期间的不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论 在输尿管结石导致的急性肾绞痛患者中,与肌内注射氢溴酸山莨菪碱比较,肌内注射酮咯酸氨丁三醇的镇痛效果更好,且不良反应更少。 展开更多
关键词 输尿管结石 急性肾绞痛 酮咯酸氨丁三醇 氢溴酸山莨菪碱
下载PDF
重复经颅磁刺激联合氢溴酸西酞普兰治疗脑卒中后睡眠障碍患者的临床疗效观察
5
作者 李静妍 张平 《中国临床新医学》 2024年第4期437-441,共5页
目的观察重复经颅磁刺激(rTMS)联合氢溴酸西酞普兰治疗脑卒中后睡眠障碍(PSSD)患者的临床疗效。方法回顾性分析2021年4月至2023年1月于新乡医学院第一附属医院接受治疗的94例PSSD患者的临床资料。根据不同治疗方案将其分为对照组和联合... 目的观察重复经颅磁刺激(rTMS)联合氢溴酸西酞普兰治疗脑卒中后睡眠障碍(PSSD)患者的临床疗效。方法回顾性分析2021年4月至2023年1月于新乡医学院第一附属医院接受治疗的94例PSSD患者的临床资料。根据不同治疗方案将其分为对照组和联合组,每组47例。对照组予氢溴酸西酞普兰治疗,联合组予rTMS联合氢溴酸西酞普兰治疗,两组均连续治疗8周。比较两组总有效率,以及不同时间点睡眠质量、负性情绪、运动阈值(MT)和炎性因子水平。结果联合组治疗后总有效率显著高于对照组(95.74%vs 78.72%;χ^(2)=6.114,P=0.013)。经治疗后,两组匹兹堡睡眠质量指数(PSQI)、失眠严重程度指数量表(ISI)、贝克抑郁量表(BDI)、贝克焦虑量表(BAI)评分以及IL-6、TNF-α、IL-2水平呈下降趋势,MT呈上升趋势,差异有统计学意义(P<0.05)。治疗4周、8周后,联合组PSQI、ISI、BDI、BAI评分以及IL-6、TNF-α、IL-2水平低于对照组,MT高于对照组,差异有统计学意义(P<0.05)。结论rTMS联合氢溴酸西酞普兰治疗PSSD患者疗效显著,可减轻炎症,提高MT,改善睡眠障碍及负性情绪。 展开更多
关键词 重复经颅磁刺激 氢溴酸西酞普兰 脑卒中后睡眠障碍 临床疗效
下载PDF
氢溴酸加兰他敏含量测定的方法比较
6
作者 刘静兰 《中国处方药》 2024年第2期54-57,共4页
目的对氢溴酸加兰他敏不同含量测定方法进行比较研究,为完善其质量标准提供依据。方法参照《中国药典》2020年版、《英国药典》2023年版、《欧洲药典》11.0版、《美国药典》2023年版和相关文献分别采用非水溶液滴定法、酸碱电位滴定法... 目的对氢溴酸加兰他敏不同含量测定方法进行比较研究,为完善其质量标准提供依据。方法参照《中国药典》2020年版、《英国药典》2023年版、《欧洲药典》11.0版、《美国药典》2023年版和相关文献分别采用非水溶液滴定法、酸碱电位滴定法和高效液相色谱法测定氢溴酸加兰他敏的含量。结果非水溶液滴定法的平均回收率为99.79%(RSD=0.46%);酸碱电位滴定法的平均回收率为100.67%(RSD=0.32%);高效液相色谱法的平均回收率分别为99.78%(RSD=0.82%)和99.85%(RSD=0.66%)。结论酸碱电位滴定法的含量测定结果偏高,非水溶液滴定法和高效液相色谱法的测定结果较为准确,更适用于氢溴酸加兰他敏的含量测定。 展开更多
关键词 氢溴酸加兰他敏 电位滴定 含量测定 高效液相色谱法
下载PDF
氢溴酸氘瑞米德韦治疗轻、中型新型冠状病毒感染的疗效和安全性
7
作者 楼颂羔 张萍 钱卫星 《浙江医学》 CAS 2024年第4期388-392,共5页
目的 探讨氢溴酸氘瑞米德韦治疗轻、中型新型冠状病毒感染的疗效和安全性。方法 收集2023年5月8日至8月5日嵊州市中医院收治的242例新型冠状病毒感染患者,根据是否接受氢溴酸氘瑞米德韦抗病毒治疗分为观察组(169例)与未服用任何抗新型... 目的 探讨氢溴酸氘瑞米德韦治疗轻、中型新型冠状病毒感染的疗效和安全性。方法 收集2023年5月8日至8月5日嵊州市中医院收治的242例新型冠状病毒感染患者,根据是否接受氢溴酸氘瑞米德韦抗病毒治疗分为观察组(169例)与未服用任何抗新型冠状病毒药物的对照组(73例)。比较两组患者人口学资料、基础疾病、本次感染首次核酸阳性时间及Ct值、疾病严重程度、药品不良反应、首次核酸转阴及临床恢复时间、是否进展为重型等信息。通过Kaplan-Meier生存分析计算病毒转阴及临床恢复时间,采用多因素Cox回归计算各因素的风险比(HR)及95%CI。结果 242例新型冠状病毒感染患者中,轻型134例(55.4%),中型108例(占44.6%);232例(95.9%)具有重型/危重型高危因素,高危因素前3位分别为心脑血管疾病(179例,74.0%)、糖尿病(77例,31.8%)、慢性肺部疾病(42例,17.4%)。两组基线特征比较,观察组患者年龄更大,合并慢性肺部疾病比例更高(均P<0.05)。观察组病毒转阴时间和临床恢复时间均显著短于对照组(均P<0.05)。多因素Cox回归分析发现病毒转阴时间的HR=2.93(95%CI:2.13~4.02),临床恢复时间HR=3.63(95%CI:2.59~5.11),均P<0.01。治疗后观察组有5例(3.0%),对照组有2例(2.7%)进展为重型,两组比较差异无统计学意义(P>0.05)。观察组发生药品不良反应9例,不良反应发生率为5.3%,未发现严重不良反应。结论 氢溴酸氘瑞米德韦是有效的口服抗新型冠状病毒药物,能显著缩短新型冠状病毒感染轻、中型患者病毒转阴及临床恢复时间,并具有较好的安全性。 展开更多
关键词 氢溴酸氘瑞米德韦 新型冠状病毒感染 病毒转阴 临床恢复 药品不良反应
下载PDF
氢溴酸加兰他敏联合甘露特钠治疗卒中后认知障碍的临床观察
8
作者 郝丕达 王阳 +4 位作者 苏冉 赵晓娟 唐宽飞 刘英科 商玉玲 《阿尔茨海默病及相关病杂志》 2024年第2期110-113,共4页
目的:探讨氢溴酸加兰他敏联合甘露特钠治疗卒中后认知障碍的临床疗效。方法:选取2022年6月至2023年12月我院收治的卒中患者130例,均合并认知功能障碍,采用信封法将患者分为联合组和氢溴酸加兰他敏组,氢溴酸加兰他敏组患者使用氢溴酸加... 目的:探讨氢溴酸加兰他敏联合甘露特钠治疗卒中后认知障碍的临床疗效。方法:选取2022年6月至2023年12月我院收治的卒中患者130例,均合并认知功能障碍,采用信封法将患者分为联合组和氢溴酸加兰他敏组,氢溴酸加兰他敏组患者使用氢溴酸加兰他敏治疗,联合组患者给予氢溴酸加兰他敏与甘露特钠联合治疗,比较两组临床疗效,并对治疗前后两组患者神经功能和认知功能评分、血清HCY和NSE水平进行比较,观察两组患者不良反应发生情况。结果:相比于氢溴酸加兰他敏组,治疗后联合组患者CSS评分较低,MMSE评分较高(P<0.05)。相比于氢溴酸加兰他敏组(86.15%),联合组患者治疗疗效(95.38%)明显较高(χ^(2)=10.883,P=0.004)。治疗后联合组患者HCY和NSE水平均明显低于氢溴酸加兰他敏组(P<0.05)。联合组患者不良反应发生率(4.17%)明显低于氢溴酸加兰他敏组(16.92%)(χ^(2)=5.123,P=0.024)。结论:氢溴酸加兰他敏联合甘露特钠治疗卒中后认知障碍的临床疗效显著,可明显提高患者神经功能和认知功能,改善血清学指标,减轻不良反应,值得临床进一步推广。 展开更多
关键词 氢溴酸加兰他敏 甘露特钠 卒中后认知障碍 认知功能
下载PDF
Development and Validation of a Stability-Indicating RP-HPLC Method for Determination of Darifenacin Hydrobromide in Bulk Drugs 被引量:2
9
作者 Mohammed Nazeerunnisa Lakshmi Garikapati Syama Sundar Bethanabhatla 《American Journal of Analytical Chemistry》 2014年第17期1239-1248,共10页
An isocratic stability-indicating reversed phase high performance liquid chromatographic method (RP-HPLC) was developed for determination of process related impurities and assay of darifenacin hydrobromide (DRF) in bu... An isocratic stability-indicating reversed phase high performance liquid chromatographic method (RP-HPLC) was developed for determination of process related impurities and assay of darifenacin hydrobromide (DRF) in bulk drugs. DRF was subjected to various stress conditions such as hydrolysis (acid, base, and neutral), oxidation, photolysis and thermal degradation as per International Conference on Harmonization (ICH Q1A(R2) and Q1B) prescribed conditions to investigate the stability-indicating ability of the method. Significant degradation was observed during acidic hydrolysis and oxidative stress conditions. The chromatographic separation was accomplished on a Prodigy C8 column (250 × 4.6 mm, 5 μm) with mobile phase consisting of 0.05 M ammonium acetate (pH adjusted to 7.2 by using ammonia solution) and methanol (36% acetonitrile) in 35:65 v/v ratio in an isocratic elution mode at a flow rate of 1.0 mL/min at 25°C. Detection of analytes was carried out using photo diode array detector at a wavelength of 215 nm. The developed LC method was validated with respect to accuracy, linearity, precision, limits of detection and quantitation and robustness as per ICH guidelines. 展开更多
关键词 DARIFENACIN hydrobromide STABILITY-INDICATING Degradation VALIDATION RP-HPLC
下载PDF
The Drying of Pyridine Hydrobromide
10
作者 René D.PeraltaRodríguez Raúl G.LópezCampos +3 位作者 Jaime Wisniak Jacinto G.Rodríguez Gómez Silvia Torres Rincón M.Esther TrevioMartínez 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 1998年第2期76-80,共5页
1 INTRODUCTIONThe drying of fine chemicals and pharmaceuticals is dominated by a number of special factorscompared to the drying of bulk chemicals.These include:very high value of product;lowthroughputs(typically,100 ... 1 INTRODUCTIONThe drying of fine chemicals and pharmaceuticals is dominated by a number of special factorscompared to the drying of bulk chemicals.These include:very high value of product;lowthroughputs(typically,100 kg·h<sup>-1</sup>);materials that frequently possess toxic properties andare often sticky,pasty and difficult to handle when wet;the moisture to be evaporated ofteninvolves solvents;and multipurpose processing plants. 展开更多
关键词 DRYING PYRIDINE hydrobromide
下载PDF
Time-effect and dose-effect of prasugrel hydrobromide acetic acid compound inhibiting platelet aggregation
11
《中国药理学通报》 CAS CSCD 北大核心 2015年第B11期178-178,共1页
Aim To evaluate the time-effect and dose-effect of prasugrel hydrobromide acetic acid compound (PHAAC) inhibiting platelet aggregation. Methods For the time-effect study, 190 Sprague-Dawley (SD) rats were devided ... Aim To evaluate the time-effect and dose-effect of prasugrel hydrobromide acetic acid compound (PHAAC) inhibiting platelet aggregation. Methods For the time-effect study, 190 Sprague-Dawley (SD) rats were devided into 19 groups (n- 10): the vehicle control group, the PHAAC groups (0.5, 1, 2, 4, 6, 24, 48, 72, 96 h) and the prasugrel hydrochloride groups (0.5, 1, 2, 4, 6, 24, 48, 72, 96 h). Rats were singly intra- gastic administration of the vehicle, the PHAAC (5 mg·kg^-1) or the prasugrel hydrochloride (5 mg · kg^-1 ), re- spectively. Blood samples were taken at each time point for the determination of platelet aggregation rate (PAR). For the dose-effect study, 110 SD rats were devided into 11 groups (n= 10): the vehicle control group, the PHAAC groups (10, 5, 2.5, 1, 0.5 mg · kg^-1, dosage of prasugrel) and the prasugrel hydrochloride groups ( 10, 5, 2.5, 1, 0.5 mg · kg^-1, dosage of prasugrel) . Blood samples were taken at 4 h after drug administration for the determination of PAR. Results Compared with the vehicle group, PHAAC has significant anti-platelet ag- gregative effects (P 〈 0.05) at the time of 0.5, 1, 2, 4, 6, 24, 48 h, and the effect at the time of 4 h was the strongest. There were no obvious differences between the effect of PHAAC (5 mg · kg^-1) and prasugrel hydrochlo- ride (5 mg · kg^-1) at each time point. Compared with the vehicle group, intragastic administration of PHAAC at the doses of 10, 5, 2.5, 1, 0.5 mg · kg^-1 could obviously inhibite the platelet aggregation, and showed a dose- dependent manner. There were no significant differences between the effect of PHAAC and prasugrel hydrochloride at the same dose. Conclusion PHAAC can inhibit platelet aggregation in a dose-dependent manner, and the effect at 4 h after drug administration is the strongest. The action strength and duration of PHAAC are similar with that of the prasugrel hydrochloride. 展开更多
关键词 PRASUGREL hydrobromide acetic acid compound platelet aggregation time-effect DOSE-EFFECT prasug-rel HYDROCHLORIDE
下载PDF
介绍新药—Eptazocine Hydrobromide
12
作者 张泓 《中国药理学通报》 CAS CSCD 北大核心 1989年第5期-,共1页
本品是日本医药工业(株)开发的镇痛剂,1987年1月被批准上市,同年4月开始销售。本品有较强的镇痛作用,其镇痛活性是镇痛新的1~2倍,但其引起的抗药性比吗啡和镇痛新轻,形成的速度也徐缓。临床主要用于各种癌症和手术后疼痛。用法:成人一... 本品是日本医药工业(株)开发的镇痛剂,1987年1月被批准上市,同年4月开始销售。本品有较强的镇痛作用,其镇痛活性是镇痛新的1~2倍,但其引起的抗药性比吗啡和镇痛新轻,形成的速度也徐缓。临床主要用于各种癌症和手术后疼痛。用法:成人一次15mg(1安瓿),皮下或肌肉注射。随症可增减剂量。 展开更多
关键词 镇痛新 戊唑辛 解热镇痛药 Eptazocine hydrobromide 过敏症
下载PDF
氢溴酸樟柳碱治疗非动脉炎性前部缺血性视神经病变的有效性和安全性评价:中国多中心非随机对照临床研究 被引量:1
13
作者 杨沫 宋宏鲁 +32 位作者 周欢粉 赖梦莹 徐全刚 孙明明 范珂 崔红培 王海燕 金鑫 孙传宾 肖庆 王影 赵子德 张铭连 常永业 陈梦平 申战省 杨晖 徐晓宇 李志清 邢东军 董玉 杨金润 任骞 李丽 张文芳 孙莉 张正培 李甦雁 刘丹岩 周娜磊 罗纳丽 刘亚东 魏世辉 《中华实验眼科杂志》 CAS CSCD 北大核心 2023年第7期646-653,共8页
目的评估口服氢溴酸樟柳碱片治疗急性期非动脉炎性前部缺血性视神经病变(NAION)的有效性和安全性。方法采用多中心非随机对照临床研究,于2020年7月至2021年5月在中国共16所医院眼科纳入首次发病的急性期NAION患者282例282眼,按照治疗方... 目的评估口服氢溴酸樟柳碱片治疗急性期非动脉炎性前部缺血性视神经病变(NAION)的有效性和安全性。方法采用多中心非随机对照临床研究,于2020年7月至2021年5月在中国共16所医院眼科纳入首次发病的急性期NAION患者282例282眼,按照治疗方法不同将患者分为2个组,其中对照组124例124眼,接受口服胞磷胆碱钠片、银杏叶提取物片/银杏叶提取物滴剂和甲钴胺片治疗;试验组158例158眼,在采用对照组治疗方法的基础上口服氢溴酸樟柳碱片1 mg/次,2次/日,连续用药2~3个月。分别于入组后1、2、3和6个月进行随访,采用标准小数视力表测定最佳矫正视力(BCVA),采用750i Humphery视野计(30-2程序)检查视野获得视野指数(VFI),采用HD 4000/HD 5000型光学相干断层扫描仪(OCT)测量视盘周围视网膜神经纤维层厚度(pRNFL),采用RTVue-XR OCT仪测定视盘放射状毛细血管网血管密度(RPC)。主要结局指标为随访末BCVA、VFI,次要结局指标为pRNFL、RPC,以及随访期间不良反应。结果共242例242眼完成主要结局指标BCVA随访,98例98眼完成主要结局指标VFI随访。在视功能变化方面,2个组患者随时间推移BCVA和VFI均有明显改善,其中试验组在各个随访时间点BCVA均显著优于对照组,VFI均显著高于对照组,差异均有统计学意义(均P<0.05)。在结构指标方面,2个组患者pRNFL均随治疗时间的延长而逐渐变薄,其中试验组在各个随访时间点pRNFL均显著薄于对照组,差异均有统计学意义(均P<0.05),但2个组间最终随访RPC差异无统计学意义(P>0.05)。试验组共有2例发生药物相关不良反应,其中1例因药物不良反应于治疗后25 d退出研究。结论口服氢溴酸樟柳碱片可以改善NAION患者的视力和视野,加速视盘水肿消退,具有良好的安全性。 展开更多
关键词 缺血性视神经病变 氢溴酸樟柳碱 治疗
下载PDF
Effects of Arecoline Hydrobromide on Taeniasis and Cysticercosis in Domestic Animals
14
作者 ZHOU Xu-zheng ZHANG Ji-yu LI Jianoyong LI Jin-shan WEI Xiao-juan NIU Jian-rong LI Bing 《Animal Husbandry and Feed Science》 CAS 2010年第6期30-32,35,共4页
Taeniasis and cysticercosis in domestic animals belong to zoonosis and seriously threaten the public health security.Especially the cysticercosis and echinococcosis caused by the tapeworm eggs have great harms to bodi... Taeniasis and cysticercosis in domestic animals belong to zoonosis and seriously threaten the public health security.Especially the cysticercosis and echinococcosis caused by the tapeworm eggs have great harms to bodies because they can attack many organs of body.According to the combination of experimental results and literature materials,the morphology and transmission mode of taenia and cysticercus,the prevalence status and monitoring of taeniasis and cysticercosis as well as the antitapeworm mechanism,comparative analysis to other drugs,expelling tapeworm tests in vitro,dose determining tests and usage notes of arecoline hydrobromide were expounded in detail.It provides a theoretical basis for prevention of taeniasis and cysticercosis and more scientific usage of arecoline hydrobromide and thus relieves the harms of taeniasis and cysticercosis and ensuring the public health security. 展开更多
关键词 家养动物 绦虫病 囊虫病 槟榔碱 氢溴酸 健康安全 人畜共患病 文献资料
下载PDF
Preparation and Crystal Structures of Two Polymorphic Forms of Bupropion Hydrobromide
15
作者 胡秀荣 向华友 +2 位作者 顾建明 张拥军 陈林深 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2011年第11期1591-1596,共6页
Two polymorphic forms (forms I and IV) of antidepressant bupropion hydrobro- mides were prepared and characterized by powder X-ray single-crystal diffractometer. Lots of commercial substances may consist of form I. Fo... Two polymorphic forms (forms I and IV) of antidepressant bupropion hydrobro- mides were prepared and characterized by powder X-ray single-crystal diffractometer. Lots of commercial substances may consist of form I. Form I crystallizes in the triclinic system, space group P1 with Z = 2, a = 7.6943(8), b = 7.9347(9), c = 13.8558(15) , α = 85.971(3), β = 85.619(2), γ = 65.974(3)°, V = 769.66(14) 3, Dc = 1.384 g/cm3, formula C13H19ClNOBr, F(000) = 328, μ = 2.83 mm-1, the final R = 0.0579 and wR = 0.1282 for 1756 observed reflections with I > 2σ(I). Another polymorphic form, Ⅳ, belongs to the orthorhombic system, space group Pbca with a = 8.6365(3), b = 12.4167(4), c = 27.7299(9) , Z = 8, V = 2973.67(17) 3, Dc = 1.432 g/cm3, formula C13H19ClNOBr, F(000) = 1312, μ = 2.93 mm-1, the final R = 0.044 and wR = 0.1093 for 2018 observed reflections with I > 2σ(I). In the crystal structure of the two polymorphic forms, expected proton transfer from HBr to amino group of bupropion molecule occurs and intramolecular and intermolecular hydrogen bonds N–H···r are formed. These interactions result in hydrogen-bond dimers in these two forms. The bupropion molecule adopts different conformations in the two investigated solid state modifications. 展开更多
关键词 晶体结构 氢溴酸 多晶型 制备 分子间 抗抑郁药 三斜晶系
下载PDF
Security of a Novel Antitapeworm Drug:Arecoline Hydrobromide
16
作者 ZHOU Xu-zheng ZHANG Ji-yu LI Jin-shan LI Jian-yong WEI Xiao-juan NIU Jian-rong LI Bing 《Animal Husbandry and Feed Science》 CAS 2010年第2期26-28,31,共4页
[Objective] To make an objective evaluation about security of a new veterinary drug-arecoline hydrobromide according to the research results and papers in recent years and supply science basis for clinical usage.[Meth... [Objective] To make an objective evaluation about security of a new veterinary drug-arecoline hydrobromide according to the research results and papers in recent years and supply science basis for clinical usage.[Method] The security of arecoline hydrobromide was evaluated based on acute toxicity tests;the ranges of safe medication,tolerability and toxicity as well as "Three-induced" effects(carcinogensis,mutagenesis and teratogenesis) and reproductive toxicity were summarized according to the combinations of experimental results,papers and clinical effects.[Result] The results of acute toxicity tests in mice and rats showed that LD50(50% lethal dosages) of arecoline hydrobromide in mice was 691.83 mg/(kg·BW) and 95% incredible range of its LD50 was 642.92-744.47 mg/(kg·BW) ,and LD50 of arecoline hydrobromide in rats was 2 054 mg/(kg·BW) and 95% incredible range of its LD50 was 1 908-2 210 mg/(kg·BW) . Its LD50 value was hundreds times higher than the recommended clinical dosage [1-5 mg/(kg·BW) ],therefore it is safe to apply in clinic. The research results of ranges of safe medication,tolerability and toxicity showed that arecoline hydrobromide could entirely dispel the dog Diphyllobothrium,Spirometra mansoni,Dipylidium mesocestoides,Lineatus and Cysticercus at dosages of 2-3 mg/(kg·BW) ,and the same effects to Railletina tapeworm of chickens and Drepanidotaenia lanceolata of duck and goose at dosages of 1-2 mg/(kg·BW) . The arecoline hydrobromide had muscarinic effects as side-effects and could cause vomiting,diarrhea and other clinical symptoms to discharge the paralyzed worm from livestock body rapidly and completely. The arecoline hydrobromide had "Three-induced" effects and reproductive toxicity when it was used as antitapeworm drug with long-term,sustained and a large number of drug usage,rather than used in clinical application with shorter time and lower dosage of administration.[Conclusion] The arecoline hydrobromide is low-toxic substance and has a certain of toxicity such as "Three-induced" effects and reproductive toxicity at high-dosages application,and there are good effects on livestock and poultry tapeworm at the clinical recommended dosages without "Three-induced" effects and reproductive toxicity. 展开更多
关键词 用药安全性 氢溴酸盐 槟榔碱 急性毒性试验 临床应用 致死剂量 生殖毒性 药品
下载PDF
Lattice potential energy and standard molar enthalpy in the formation of 1-dodecylamine hydrobromide (1-C_(12)H_(25)NH_3 ·Br)(s)
17
作者 刘玉普 邸友莹 +3 位作者 淡文彦 何东华 孔玉霞 杨伟伟 《Chinese Physics B》 SCIE EI CAS CSCD 2011年第2期538-543,共6页
This paper reports that 1-dodecylamine hydrobromide (1-C 12 H 25 NH 3 ·Br)(s) has been synthesized using the liquid phase reaction method.The lattice potential energy of the compound 1-C 12 H 25 NH 3 ·Br and... This paper reports that 1-dodecylamine hydrobromide (1-C 12 H 25 NH 3 ·Br)(s) has been synthesized using the liquid phase reaction method.The lattice potential energy of the compound 1-C 12 H 25 NH 3 ·Br and the ionic volume and radius of the 1-C 12 H 25 NH + 3 cation are obtained from the crystallographic data and other auxiliary thermodynamic data.The constant-volume energy of combustion of 1-C 12 H 25 NH 3 ·Br(s) is measured to be c U o m (1-C 12 H 25 NH 3 ·Br,s) =-(7369.03±3.28) kJ·mol 1 by means of an RBC-II precision rotating-bomb combustion calorimeter at T =(298.15±0.001) K.The standard molar enthalpy of combustion of the compound is derived to be c H o m (1-C 12 H 25 NH 3 ·Br,s)=-(7384.52±3.28) kJ·mol 1 from the constant-volume energy of combustion.The standard molar enthalpy of formation of the compound is calculated to be f H o m (1-C 12 H 25 NH 3 ·Br,s)=-(1317.86±3.67) kJ·mol 1 from the standard molar enthalpy of combustion of the title compound and other auxiliary thermodynamic quantities through a thermochemical cycle. 展开更多
关键词 氢溴酸盐 十二烷基胺 摩尔焓 标准 势能 晶格 标题化合物 阳离子半径
原文传递
高效液相色谱法同时测定镇咳口服液中盐酸去氧肾上腺素、马来酸氯苯那敏、氢溴酸右美沙芬
18
作者 李鑫 代民言 +2 位作者 宁星 苗利 王明志 《化学分析计量》 CAS 2023年第7期70-73,共4页
建立同时测定镇咳口服液中盐酸去氧肾上腺素、马来酸氯苯那敏、氢溴酸右美沙芬含量的高效液相色谱方法。采用ACE Excel super C_(18)色谱柱(250 mm×4.6 mm,5μm)为分离柱,流动相A为磷酸二氢钾与辛烷磺酸钠缓冲盐-甲醇溶液(体积比... 建立同时测定镇咳口服液中盐酸去氧肾上腺素、马来酸氯苯那敏、氢溴酸右美沙芬含量的高效液相色谱方法。采用ACE Excel super C_(18)色谱柱(250 mm×4.6 mm,5μm)为分离柱,流动相A为磷酸二氢钾与辛烷磺酸钠缓冲盐-甲醇溶液(体积比为92∶8),流动相B为磷酸二氢钾与辛烷磺酸钠缓冲盐-甲醇溶液(体积比为12∶88),梯度洗脱,流量为1.0 mL/min,检测波长为220 nm,柱温为35℃,进样体积为10μL。盐酸去氧肾上腺素、马来酸氯苯那敏、氢溴酸右美沙芬质量浓度分别在38.876~64.793、16.256~24.384、76.723~127.872μg/mL范围内与对应色谱峰面积线性相关,相关系数分别为0.9999、0.9997、0.9998。样品中3种成分含量测定结果的相对标准偏差为0.28%~0.42%(n=6),加标回收率为98.65%~99.65%。该方法操作简便、稳定,具有可再现性,可用于镇咳口服液中盐酸去氧肾上腺素、马来酸氯苯那敏、氢溴酸右美沙芬含量的同时测定。 展开更多
关键词 盐酸去氧肾上腺素 马来酸氯苯那敏 氢溴酸右美沙芬 镇咳口服液 高效液相色谱法
下载PDF
氢溴酸樟柳碱治疗缺血性视网膜中央静脉阻塞对视力、视野及生活质量的影响
19
作者 王俊东 《中国现代药物应用》 2023年第14期130-133,共4页
目的分析氢溴酸樟柳碱治疗缺血性视网膜中央静脉阻塞对患者视力、视野及生活质量的影响。方法64例(64眼)缺血性视网膜中央静脉阻塞患者,按双盲法分为对照组和观察组,每组32例。对照组患者采用常规治疗,观察组患者在对照组基础上联合氢... 目的分析氢溴酸樟柳碱治疗缺血性视网膜中央静脉阻塞对患者视力、视野及生活质量的影响。方法64例(64眼)缺血性视网膜中央静脉阻塞患者,按双盲法分为对照组和观察组,每组32例。对照组患者采用常规治疗,观察组患者在对照组基础上联合氢溴酸樟柳碱治疗。比较两组患者视力改善效果、视野恢复效果及治疗前后视功能指标[最佳矫正视力(BCVA)、黄斑中心凹视网膜厚度(CMT)]、生活质量评分。结果观察组患者视力改善率为68.8%,高于对照组的37.5%,差异具有统计学意义(P<0.05)。治疗后,观察组患者BCVA(0.54±0.21)显著高于对照组的(0.31±0.20),CMT(198.69±25.23)μm显著低于对照组的(236.12±25.15)μm,差异具有统计学意义(P<0.05)。观察组患者视野恢复总有效率为56.3%,高于对照组的31.3%,差异具有统计学意义(P<0.05)。治疗后,两组患者生活质量评分均高于本组治疗前,且观察组患者生活质量评分(74.02±14.83)分高于对照组的(66.36±13.85)分,差异具有统计学意义(P<0.05)。结论氢溴酸樟柳碱治疗缺血性视网膜中央静脉阻塞能显著改善患者的视力、视野,提升患者的生活质量,具有重要价值。 展开更多
关键词 氢溴酸樟柳碱 缺血性视网膜中央静脉阻塞 视力 视野 生活质量
下载PDF
氟比洛芬酯与双氯芬酸钠栓分别联合氢溴酸山莨菪碱治疗急性肾绞痛的疗效比较
20
作者 李仁杰 陈炳水 《基层医学论坛》 2023年第16期16-18,共3页
目的 比较氟比洛芬酯注射液与双氯芬酸钠栓分别联合氢溴酸山莨菪碱治疗急性肾绞痛的疗效。方法选取258例于2018年1月-2021年5月在莆田学院附属医院接受治疗的急性肾绞痛患者,均采用药物治疗,其中采用氟比洛芬酯注射液加氢溴酸山莨菪碱... 目的 比较氟比洛芬酯注射液与双氯芬酸钠栓分别联合氢溴酸山莨菪碱治疗急性肾绞痛的疗效。方法选取258例于2018年1月-2021年5月在莆田学院附属医院接受治疗的急性肾绞痛患者,均采用药物治疗,其中采用氟比洛芬酯注射液加氢溴酸山莨菪碱胆碱注射液138例(A组),采用双氯芬酸钠栓加氢溴酸山莨菪碱胆碱注射液120例(B组),对2组患者药物镇痛起效时间、镇痛总体有效率,药物不良反应情况以及6 h再发生率进行比较。结果A组患者镇痛效果总有效率(98.55%)高于B组(92.5%),患者用药后镇痛起效时间为(21.8±6.8)min,短于B组的(30.8±5.6)min,不良反应发生情况少于B组,6 h再发生肾绞痛例数较B组少,差异均有统计学意义(P<0.05)。结论氟比洛芬酯镇痛起效时间快于双氯芬酸钠栓,镇痛效果更好,且不良反应发生率低,镇痛后持续时间比较长,再发生率低,值得临床首选。 展开更多
关键词 急性肾绞痛 氟比洛芬酯 双氯芬酸钠栓 氢溴酸山莨菪碱 联合治疗
下载PDF
上一页 1 2 30 下一页 到第
使用帮助 返回顶部